Related Experiment Video
Updated: Dec 10, 2025
09:32
Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
12.7K
Algorithms in clinical epilepsy practice: Can they really help us predict epilepsy outcomes?
1Cleveland Clinic, Cleveland, Ohio.
Epilepsia
|September 2, 2020
Summary
This review explores how cognitive biases affect epilepsy surgery decisions. It suggests using algorithms and statistical models to improve patient outcome prediction, moving beyond subjective clinical judgment for better epilepsy care.
Area of Science:
- Neurology
- Medical Decision-Making
- Biostatistics
Background:
- Technological advancements enhance epilepsy localization and electrophysiology studies for surgical preparation.
- Current decision-making and outcome prediction rely heavily on subjective clinical judgment.
- This reliance may limit improvements in surgical outcomes for epilepsy patients.
Purpose of the Study:
- To review cognitive biases impacting medical decision-making in epilepsy surgery.
- To present data on the use of algorithms and statistical models in healthcare.
- To discuss the application of these models in epilepsy care.
Main Methods:
- Literature review of cognitive biases in medical decision-making.
- Review of statistical models and algorithms in general healthcare.
- Analysis of potential applications in epilepsy surgery patient management.
Main Results:
- Cognitive biases can significantly interfere with clinical judgment.
- Algorithms and statistical models offer objective approaches to decision support.
- Data suggests potential for improved accuracy in outcome prediction.
Conclusions:
- Integrating objective models into epilepsy care could enhance decision-making.
- Addressing cognitive biases and utilizing data-driven approaches may improve patient outcomes.
- Further research is warranted to validate these methods in epilepsy surgery.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.0K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
01:13Seizures: Classification
1.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
685
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
685